CURRENT ISSUE
IJME COVER Apr -Jun 2025 color
The values of fairness, excellence, and respect are supposed to be nurtured through participation in Sports. But with sport becoming…
THEME EDITORIAL
Sports ethics: New challenges for new times
Research Articles
Children with cancer in India: An ethical framework for practice
Using case-based role-play to learn professionalism in Pharmacology
Read More >>
Online First
Challenges in obtaining informed consent for health research from dependent older persons in the Indian socio-cultural context

In this brief commentary, we share our experience of obtaining informed consent from older persons living in the community, dependent on their sons, daughters or in-laws. We present a scenario in which for our community-based cluster randomised controlled trial on ...

Response to critique by Indira Chakravarthi

Indira Chakravarthi’s critique relates to our paper published in the British Medical Journal in 2021 titled “Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial...

Ethical issues in a cluster randomised controlled trial for evaluating effectiveness of screening for breast cancer by clinical breast examination in India

This article discusses issues of ethical concern in the conduct of a prospective, cluster randomised controlled trial for evaluating effectiveness of screening by clinical breast examination for downstaging of breast cancer, and in reducing mortality from the disea...

Global disparities and data transparency in editorial boards of prominent Internal medicine journals including allied super specialities: A wake-up call

Background: Global healthcare research suffers from inequalities, favouring high-income countries, which hampers fair healthcare access. Low and lower-middle-income nations face limited participation and editorial bias, posing concerns for research integrity. Poten...

Off-label use of baclofen for alcohol use disorders in India: no ethics without science

Off-label use of drugs, when not supported by sound scientific evidence, hinders the development of evidence-based medicine and therapeutic innovation, is costly to the healthcare system, and exposes patients to unnecessary risks, including mortality, for an uncert...

Help IJME keep its content free. You can support us from as little as Rs. 500 Make a Donation